Inflammation

, Volume 37, Issue 2, pp 396–401 | Cite as

Muckle–Wells Cryopyrinopathy: Complex Phenotyping and Response to Therapy in a New Multiplex Kindred

  • Alexander P. Headley
  • Frank Cordingley
  • Phillip N. Hawkins
  • D. Sean Riminton
Article
  • 244 Downloads

Abstract

Muckle–Wells syndrome (MWS) is a member of the cryopyrin-associated periodic syndrome family of auto-inflammatory diseases, originally described as a triad of urticaria, sensorineural deafness and amyloidosis. IL-1 blockade is a proven therapy for MWS. The clinical, laboratory and genotypic characteristics of a novel kindred of five individuals with Muckle–Wells syndrome are described. Response to IL-1 blockade therapy in the proband was evaluated. All five affected family members experienced symptoms of multi-organ inflammation. Lead time between symptom onset and diagnosis was approximately 30 years in the proband. Fever was not a universal feature in all affected family members. Anti-IL-1 therapy in the proband resulted in improvements in patient-reported symptoms, inflammatory markers, auditory acuity and reversal of her infertility. Muckle–Wells syndrome is a rare, multisystem, auto-inflammatory syndrome. Delay in diagnosis prevents effective treatment. We propose reversal of infertility to be among the potential benefits of IL-1 inhibition in this disease.

KEY WORDS

cryopyrin-associated periodic syndromes autoinflammatory syndromes infertility sensorineural deafness interleukin-1 

Notes

Acknowledgments

The authors wish to thank the Department of Molecular Medicine, Concord Hospital, Australia for their assistance in preparing the DNA sample. We also wish to thank the National Amyloidosis Centre, University College London Medical School, London, United Kingdom for their help in molecular diagnosis and Dr Sam Mehr at the Children’s Hospital, Westmead, Australia for his assistance.

Financial Support

None declared

References

  1. 1.
    Hoffman, H.M., J.L. Mueller, D.H. Broide, A.A. Wanderer, and R.D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genetics 29: 301–305.PubMedCrossRefGoogle Scholar
  2. 2.
    Schroder, K., R. Zhou, and J. Tschopp. 2010. The NLRP3 inflammasome: a sensor for metabolic danger? Science (New York, N.Y.) 327: 296–300.CrossRefGoogle Scholar
  3. 3.
    Zhou, R., A.S. Yazdi, P. Menu, and J. Tschopp. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221–225.PubMedCrossRefGoogle Scholar
  4. 4.
    Tschopp, J. 2011. Mitochondria: Sovereign of inflammation? European Journal of Immunology 41: 1196–1202.PubMedCrossRefGoogle Scholar
  5. 5.
    Shimada, K., T.R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, V.K. Ramanujan, A.J. Wolf, L. Vergnes, D.M. Ojcius, A. Rentsendorj, M. Vargas, C. Guerrero, Y. Wang, K.A. Fitzgerald, D.M. Underhill, T. Town, and M. Arditi. 2012. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401–414.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Aksentijevich, I., C. DPutnam, E.F. Remmers, J.L. Mueller, J. Le, R.D. Kolodner, Z. Moak, M. Chuang, F. Austin, R. Goldbach-Mansky, H.M. Hoffman, and D.L. Kastner. 2007. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis and Rheumatism 56: 1273–85.PubMedCrossRefGoogle Scholar
  7. 7.
    Muckle, T.J., and M. Wells. 1962. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. The Quarterly Journal of Medicine 31: 235–248.PubMedGoogle Scholar
  8. 8.
    Yamazaki, T., J. Masumoto, K. Agematsu, N. Sawai, S. Kobayashi, T. Shigemura, K. Yasui, and K. Koike. 2008. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis and Rheumatism 58: 864–868.PubMedCrossRefGoogle Scholar
  9. 9.
    Rynne, M., C. Maclean, A. Bybee, M.F. McDermott, and P. Emery. 2006. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Annals of the Rheumatic Diseases 65: 533–534.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Murphy, G., M. Daly, M. O’Sullivan, J. Stack, D. Rowczenio, H. Lachmann, F. Shanahan, S. Harney, P. Hawkins, and M. Molloy. 2011. An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K. Rheumatology (Oxford) 50: 419–420.CrossRefGoogle Scholar
  11. 11.
    Kuemmerle-Deschner, J.B., P.N. Tyrrell, I. Koetter, H. Wittkowski, A. Bialkowski, N. Tzaribachev, P. Lohse, A. Koitchev, C. Deuter, D. Foell, and S.M. Benseler. 2011. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis and Rheumatism 63: 840–849.PubMedCrossRefGoogle Scholar
  12. 12.
    Aganna, E., F. Martinon, P.N. Hawkins, J.B. Ross, D.C. Swan, D.R. Booth, H.J. Lachmann, A. Bybee, R. Gaudet, P. Woo, C. Feighery, F.E. Cotter, M. Thome, G.A. Hitman, J. Tschopp, and M.F. McDermott. 2002. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis and Rheumatism 46: 2445–2452.PubMedCrossRefGoogle Scholar
  13. 13.
    Hoffman, H.M., F. Wolfe, P. Belomestnov, and S.J. Mellis. 2008. Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity. Current Medical Research and Opinion 24: 2531–2543.PubMedCrossRefGoogle Scholar
  14. 14.
    Lieberman, A., M.E. Grossman, and D.N. Silvers. 1998. Muckle-Wells syndrome: case report and review of cutaneous pathology. Journal of the American Academy of Dermatology 39: 290–291.PubMedCrossRefGoogle Scholar
  15. 15.
    Hawkins, P.N., H.J. Lachmann, E. Aganna, and M.F. McDermott. 2004. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis and Rheumatism 50: 607–612.PubMedCrossRefGoogle Scholar
  16. 16.
    Kuemmerle-Deschner, J.B., A. Koitschev, K. Ummenhofer, S. Hansmann, S.K. Plontke, C. Koitschev, I. Koetter, E. Angermair, and S.M. Benseler. 2013. Hearing loss in Muckle-Wells syndrome. Arthritis and Rheumatism 65: 824–831.PubMedCrossRefGoogle Scholar
  17. 17.
    Kagami, S., H. Saeki, Y. Kuwano, S. Imakado, and K. Tamaki. 2006. A probable case of Muckle-Wells syndrome. Journal of Dermatology 33: 118–121.PubMedCrossRefGoogle Scholar
  18. 18.
    Nazzari, G, G. Desirello, and F. Crovato. 1995. Recurrent urticarial skin eruption since infancy. Muckle-Wells syndrome (MWS). Archives of Dermatology 131: 81–2, 4–5Google Scholar
  19. 19.
    Hawkins, P.N., H.J. Lachmann, and M.F. McDermott. 2003. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. The New England Journal of Medicine 348: 2583–2584.PubMedCrossRefGoogle Scholar
  20. 20.
    Hoffman, H.M., M.L. Throne, N.J. Amar, M. Sebai, A.J. Kivitz, A. Kavanaugh, S.P. Weinstein, P. Belomestnov, G.D. Yancopoulos, N. Stahl, and S.J. Mellis. 2008. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis and Rheumatism 58: 2443–2452.PubMedCrossRefGoogle Scholar
  21. 21.
    Lachmann, H.J., I. Kone-Paut, J.B. Kuemmerle-Deschner, K.S. Leslie, E. Hachulla, P. Quartier, X. Gitton, A. Widmer, N. Patel, and P.N. Hawkins. 2009. Use of canakinumab in the cryopyrin-associated periodic syndrome. The New England Journal of Medicine 360: 2416–2425.PubMedCrossRefGoogle Scholar
  22. 22.
    Mirault, T., D. Launay, L. Cuisset, E. Hachulla, M. Lambert, V. Queyrel, T. Quemeneur, S. Morell-Dubois, and P.-Y. Hatron. 2006. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis and Rheumatism 54: 1697–1700.PubMedCrossRefGoogle Scholar
  23. 23.
    Lane, T., J.M. Loeffler, D.M. Rowczenio, J.A. Gilbertson, A. Bybee, T.L. Russell, J.D. Gillmore, A.D. Wechalekar, P.N. Hawkins, and H.J. Lachmann. 2013. AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis and Rheumatism 65: 1116–1121.PubMedCrossRefGoogle Scholar
  24. 24.
    Grassegger, A., R. Greil, J. Feichtinger, P. Fritsch, and H. Hintner. 1991. Urticarial vasculitis as a symptom of Muckle-Wells syndrome? Hautarzt 42: 116–119.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Alexander P. Headley
    • 1
  • Frank Cordingley
    • 2
  • Phillip N. Hawkins
    • 3
  • D. Sean Riminton
    • 1
  1. 1.Department of ImmunologyConcord HospitalConcordAustralia
  2. 2.Department of HaematologyFremantle HospitalFremantleAustralia
  3. 3.National Amyloidosis CentreUniversity College London Medical SchoolLondonUK

Personalised recommendations